Telesis Bio Incの簿価
Telesis Bio Incの簿価 は何ですか。
Telesis Bio Incの簿価 は0.00です。
簿価 の定義は何ですか。
1株当たりの帳簿価額は、会社の資産から会社の負債を差し引いた数を発行済株式数で割ったものです。
The book value of a company is the value of its assets according to its balance sheet account balance. For assets, the value is based on the original cost of the asset less any depreciation, amortization or impairment costs made against the asset. Traditionally, a company's book value is its total assets minus intangible assets and liabilities. However, in practice, depending on the source of the calculation, book value may variably include goodwill, intangible assets, or both. The value inherent in its workforce, part of the intellectual capital of a company, is always ignored. The book value of a company may be also referred as with the term net asset value.
The book value per share is the the balance sheet equity value divided by the number of shares outstanding at the date of the balance sheet. Book value per share can be used to generate a measure of comprehensive earnings, when the opening and closing values are reconciled. The sale of shares/units by a business increases the total book value. Book value per share will increase if the additional shares are issued at a price higher than the pre-existing book value per share. The purchase of its own shares by a business will decrease total book value. Book value per share will decrease if more is paid for them than was received when originally issued. Dividends paid out will decrease book value per share value.
NASDAQのセクタHealth Careにおける簿価 の企業と比べるTelesis Bio Inc
Telesis Bio Incは何をしますか。
sgi-dna, a wholly owned subsidiary of synthetic genomics inc., provides genomic solutions to advance scientific discovery. sgi-dna’s ever expanding suite of products, services, reagents, bioinformatics tools and instrumentation enables scientists to discover, design and build novel solutions for basic research, as well as for biomedical and industrial applications. sgi-dna’s genomic services include whole genome sequencing, dna synthesis, library design, bioinformatics, cell engineering, and plasmid dna cloning and purification. sgi-dna’s reagents include a complete suite of gibson assembly® and site directed mutagenesis kits as well as optimized cell lines such as vmax™ a novel, fast growing host system for molecular biology. to further enable synthetic biology workflows, sgi-dna offers the bioxp™ 3200 system. this fully automated genomics workstation allows the creation of double stranded dna fragments, automated cloning, as well as next generation sequencing dna library preparation.
Telesis Bio Incと類似の簿価
- Genesys Industriesの簿価 は0.00です。
- Leaf Resourcesの簿価 は0.00です。
- Ampio Pharmaceuticals Incの簿価 は0.00です。
- PARKDの簿価 は0.00です。
- Bluechiipの簿価 は0.00です。
- dynaCERTの簿価 は0.00です。
- Telesis Bio Incの簿価 は0.00です。
- Constellation Technologiesの簿価 は0.00です。
- Mount Ridley Minesの簿価 は0.00です。
- Traka Resourcesの簿価 は0.00です。
- Peppermint Innovationの簿価 は0.00です。
- Colonnade Acquisitionの簿価 は0.00です。
- DynaCERTの簿価 は0.00です。